Anti-PFKP antibody [OTI1D6]
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(19 Publications)
Mouse Monoclonal PFKP antibody. Suitable for WB, IHC-P, ICC/IF, Flow Cyt (Intra) and reacts with Transfected cell lysate, Mouse, Rat, Human, Recombinant full length protein - Human samples. Cited in 19 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human PFKP.
View Alternative Names
PFKF, PFKP, ATP-PFK, PFK-P, 6-phosphofructokinase type C, Phosphofructo-1-kinase isozyme C, Phosphohexokinase, PFK-C
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/150 dilution staining PFKP in Paraffin-embedded Human Kidney carcinoma tissue by Immunohistochemistry.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/100 dilution staining PFKP in Jurkat cells by Flow Cytometry (Intracellular) (Red) compared to a nonspecific negative control antibody (Blue).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/150 dilution staining PFKP in Paraffin-embedded Human Colon tissue by Immunohistochemistry.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/150 dilution staining PFKP in Paraffin-embedded Human Lung carcinoma tissue by Immunohistochemistry.
- WB
Unknown
Western blot - Anti-PFKP antibody [OTI1D6] (AB119796)
HEK293T cell lysates were generated from transient transfection of the cDNA clone (RC200673)
All lanes:
Western blot - Anti-PFKP antibody [OTI1D6] (ab119796) at 1/500 dilution
Lane 1:
HEK293T cell lysate transfected with pCMV6-ENTRY control cDNA at 5 µg
Lane 2:
HEK293T cell lysate transfected with pCMV6-ENTRY PFKP cDNA at 5 µg
Predicted band size: 86 kDa
false
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/100 dilution staining PFKP in COS7 cells transiently transfected with pCMV6-ENTRY PFKP by Immunofluorescence.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/150 dilution staining PFKP in Paraffin-embedded Human Tonsil tissue by Immunohistochemistry.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/150 dilution staining PFKP in Paraffin-embedded Human Endometrium tissue by Immunohistochemistry.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/150 dilution staining PFKP in Paraffin-embedded Human Ovary adenocarcinoma tissue by Immunohistochemistry.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/150 dilution staining PFKP in Paraffin-embedded Human Bladder carcinoma tissue by Immunohistochemistry.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PFKP antibody [OTI1D6] (AB119796)
ab119796 at 1/150 dilution staining PFKP in Paraffin-embedded Human Endometrium adenocarcinoma tissue by Immunohistochemistry.
- WB
Unknown
Western blot - Anti-PFKP antibody [OTI1D6] (AB119796)
HEK293T cell lysates were generated from transient transfection of the cDNA clone (RC200673)
All lanes:
Western blot - Anti-PFKP antibody [OTI1D6] (ab119796) at 1/500 dilution
Lane 1:
HepG2 cell extract at 35 µg
Lane 2:
HeLa cell extract at 35 µg
Lane 3:
SVT2 cell extract at 35 µg
Lane 4:
A549 cell extract at 35 µg
Lane 5:
COS7 cell extract at 35 µg
Lane 6:
Jurkat cell extract at 35 µg
Lane 7:
MDCK cell extract at 35 µg
Lane 8:
PC12 cell extract at 35 µg
Lane 9:
MCF7 cell extract at 35 µg
Predicted band size: 86 kDa
false
- WB
Lab
Western blot - Anti-PFKP antibody [OTI1D6] (AB119796)
Lanes 1-3 : Merged signal (red and green). Green - ab119796 observed at 86 kDa. Red - loading control ab181602 observed at 36 kDa.
ab119796 Anti-PFKP antibody [OTI1D6] was shown to specifically react with PFKP in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265136 (knockout cell lysate ab257580) was used. Wild-type and PFKP knockout samples were subjected to SDS-PAGE. ab119796 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PFKP antibody [OTI1D6] (ab119796) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
PFKP knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human PFKP knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-pfkp-knockout-hela-cell-line-ab265136'>ab265136</a>)
Lane 3:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-680rd-preadsorbed-ab216777'>ab216777</a>) at 1/10000 dilution
Predicted band size: 86 kDa
Observed band size: 86 kDa
false
Reactivity data
Product details
The clone number has been updated from 1D6 to OTI1D6, both clone numbers name the same clone.
Dilute in PBS (pH 7.3) before use.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PFKP plays an essential role in maintaining energy supply ensuring efficient glycolysis during high energy demands. It associates with other isoforms PFKM (muscle) and PFKL (liver) to form a tetrameric complex which can adapt its activity based on the energy needs of the cell. This adaptability defines its contribution to cellular metabolism regulation considering energy substrates and signaling molecules.
Pathways
The function of PFKP ties closely to glycolysis and the larger metabolic pathways managing energy production such as the tricarboxylic acid (TCA) cycle. Within these pathways PFKP interacts with other metabolic regulators including AMP-activated protein kinase (AMPK) which influences cell metabolism in response to energy availability. Connections with PFKL and PFKM reveal that PFKP's activity relates to the overall glycolytic flux and energy balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (19)
Recent publications for all applications. Explore the full list and refine your search
European journal of medical research 30:765 PubMed40830974
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 24:310 PubMed39252014
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e18465 PubMed39022816
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e30959 PubMed38813227
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:816 PubMed38086793
2023
Applications
Unspecified application
Species
Unspecified reactive species
BioFactors (Oxford, England) 49:600-611 PubMed36585756
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 20:194 PubMed36536346
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 18:492-506 PubMed35415308
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed34073074
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 23: PubMed33236133
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com